A 78-year-old Japanese man with a history of right upper lobectomy due to lung abscess was transferred to our emergency department for dyspnea. The patient experienced progressive episodes of exertional dyspnea over a two-year period because of underlying chronic obstructive pulmonary disease (COPD), which was unmanaged. The patient was a former smoker. He smoked 40 cigarettes per day for 28 years. On the day before admission, he experienced a significantly worse episode of dyspnea triggering his decision to visit a local clinic. On arrival, he presented with the following: body temperature, 37.3°C; respiratory rate, 30/minute; and oxygen saturation, 74% (room air). A chest X-ray ([Figure 1](#f1){ref-type="fig"}) revealed bilateral opacities peripherally. Chest computed tomography (CT) ([Figure 2](#f2){ref-type="fig"}) revealed diffuse low attenuation areas and increased concentrations along the circumference of the emphysema. Three weeks before admission, his wife was hospitalized because of COVID-19. A reverse transcription--polymerase chain reaction test for SARS-CoV-2 was positive.

![Chest X-ray. A chest X-ray revealed bilateral opacities peripherally.](tpmd200605f1){#f1}

![Computed tomography (CT) of the lung. Chest CT revealed diffuse low attenuation areas and increased concentrations along the circumference of the emphysema in a peripheral, bilateral, posterior, and lower lung zone distribution.](tpmd200605f2){#f2}

Chest CT findings related to COVID-19 typically present with ground-glass opacities with or without consolidation in a peripheral, bilateral, posterior, and diffuse or lower lung zone distribution. Ground-glass opacities have also been reported to have round morphology or a "crazy paving" pattern.^[@b1]^ However, the combination of COVID-19 pneumonia and advanced structural lung damage caused by COPD can culminate in atypical CT findings such as a peripheral "Swiss cheese" appearance.^[@b2]^ The peripheral distribution of "Swiss cheese" appearances may denote COVID-19 pneumonia in patients with underlying COPD and could be exploited for use in its diagnosis.
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